JP2017538779A5 - - Google Patents

Download PDF

Info

Publication number
JP2017538779A5
JP2017538779A5 JP2017538458A JP2017538458A JP2017538779A5 JP 2017538779 A5 JP2017538779 A5 JP 2017538779A5 JP 2017538458 A JP2017538458 A JP 2017538458A JP 2017538458 A JP2017538458 A JP 2017538458A JP 2017538779 A5 JP2017538779 A5 JP 2017538779A5
Authority
JP
Japan
Prior art keywords
nebulizer
seq
polypeptide
composition
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2017538458A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017538779A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/073487 external-priority patent/WO2016055656A1/en
Publication of JP2017538779A publication Critical patent/JP2017538779A/ja
Publication of JP2017538779A5 publication Critical patent/JP2017538779A5/ja
Withdrawn legal-status Critical Current

Links

JP2017538458A 2014-10-10 2015-10-09 Rsv感染の治療方法 Withdrawn JP2017538779A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201462062469P 2014-10-10 2014-10-10
US62/062,469 2014-10-10
US201462067096P 2014-10-22 2014-10-22
US62/067,096 2014-10-22
US201462074842P 2014-11-04 2014-11-04
US62/074,842 2014-11-04
EP14193094.1 2014-11-13
EP14193094 2014-11-13
PCT/EP2015/073487 WO2016055656A1 (en) 2014-10-10 2015-10-09 Methods of treating rsv infections

Publications (2)

Publication Number Publication Date
JP2017538779A JP2017538779A (ja) 2017-12-28
JP2017538779A5 true JP2017538779A5 (https=) 2018-11-08

Family

ID=83280658

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017538458A Withdrawn JP2017538779A (ja) 2014-10-10 2015-10-09 Rsv感染の治療方法

Country Status (10)

Country Link
US (1) US10561805B2 (https=)
EP (1) EP3204041A1 (https=)
JP (1) JP2017538779A (https=)
KR (1) KR20170093120A (https=)
CN (1) CN107206069A (https=)
AU (1) AU2015329936A1 (https=)
CA (1) CA2963037A1 (https=)
RU (1) RU2017115670A (https=)
SG (1) SG11201702688UA (https=)
WO (1) WO2016055656A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3204095T3 (pl) * 2014-10-10 2019-10-31 Ablynx Nv Urządzenie do inhalacji do stosowania w terapii aerozolowej chorób układu oddechowego
CA2944687C (en) * 2015-10-13 2019-09-10 Hill-Rom Services Pte Limited Percussive chest therapy apparatus having a nebulizer interface
CA3022697A1 (en) 2016-05-02 2017-11-09 Ablynx Nv Treatment of rsv infection
WO2017192773A1 (en) 2016-05-03 2017-11-09 Pneuma Respiratory, Inc. Methods for treatment of pulmonary lung diseases with improved therapeutic efficacy and improved dose efficiency
EP3452150B1 (en) 2016-05-03 2024-01-17 Pneuma Respiratory, Inc. Droplet delivery device for delivery of fluids to the pulmonary system
EP4624054A3 (en) 2016-05-03 2025-11-19 Pneuma Respiratory, Inc. Methods for generating and delivering droplets to the pulmonary system using a droplet delivery device
WO2017192774A1 (en) 2016-05-03 2017-11-09 Pneuma Respiratory, Inc. Methods for the systemic delivery of therapeutic agents to the pulmonary system using a droplet delivery device
WO2017192782A1 (en) 2016-05-03 2017-11-09 Pneuma Respiratory, Inc. Systems and methods comprising a droplet delivery device and a breathing assist device for therapeutic treatment
WO2018099968A1 (en) 2016-11-29 2018-06-07 Ablynx N.V. Treatment of infection by respiratory syncytial virus (rsv)
WO2018213834A1 (en) 2017-05-19 2018-11-22 Pneuma Respiratory, Inc. Dry powder delivery device and methods of use
CN111526914A (zh) 2017-10-04 2020-08-11 精呼吸股份有限公司 电子呼吸致动式直线型液滴输送装置及其使用方法
EP4344719B1 (en) * 2017-10-17 2025-12-31 Pneuma Respiratory, Inc. NASAL MEDICATION ADMINISTRATION DEVICE
JP2021502178A (ja) 2017-11-08 2021-01-28 ニューマ・リスパイラトリー・インコーポレイテッド 小容積アンプルを有して呼吸により電気的に作動するインライン液滴送達装置および使用方法
US11185252B2 (en) * 2018-10-18 2021-11-30 Koninklijke Philips N.V. Determining a risk level posed by an air pollutant
EP3968963A4 (en) 2019-05-16 2023-02-01 Aerovate Therapeutics, Inc. IMATINIB FORMULATIONS, THEIR PREPARATION AND USES
WO2021230875A1 (en) * 2020-05-14 2021-11-18 Healthy Humming, LLC Therapeutic device for treatment of conditions relating to the sinuses, nasal cavities, ear, nose and throat
US11793945B2 (en) 2021-06-22 2023-10-24 Pneuma Respiratory, Inc. Droplet delivery device with push ejection
CN119768202A (zh) 2022-07-18 2025-04-04 精呼吸股份有限公司 小步长高分辨率气溶胶生成系统及方法
AR131494A1 (es) 2022-12-23 2025-03-26 Ablynx Nv Vehículos de conjugación a base de proteína
TW202543670A (zh) 2023-12-22 2025-11-16 比利時商艾伯霖克斯公司 用於核內投予之基於蛋白質的接合載劑
TW202602487A (zh) * 2024-03-07 2026-01-16 瑞士商Csl貝林股份有限公司 呼吸系統疾病的治療與預防
US20260007757A1 (en) 2024-06-18 2026-01-08 Ablynx Nv Antibody-recruiting molecules

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0368684B2 (en) 1988-11-11 2004-09-29 Medical Research Council Cloning immunoglobulin variable domain sequences.
AU701578B2 (en) 1992-08-21 1999-02-04 Vrije Universiteit Brussel Immunoglobulins devoid of light chains
AU3295299A (en) 1998-02-19 1999-09-06 Xcyte Therapies, Inc. Compositions and methods for regulating lymphocyte activation
US20060073141A1 (en) 2001-06-28 2006-04-06 Domantis Limited Compositions and methods for treating inflammatory disorders
WO2003062370A2 (en) * 2001-07-19 2003-07-31 Perlan Therapeutics, Inc. Multimeric proteins and methods of making and using same
US9320792B2 (en) 2002-11-08 2016-04-26 Ablynx N.V. Pulmonary administration of immunoglobulin single variable domains and constructs thereof
US7461263B2 (en) 2003-01-23 2008-12-02 Unspam, Llc. Method and apparatus for a non-revealing do-not-contact list system
AU2003264053A1 (en) 2003-08-12 2005-03-10 William M. Yarbrough Treatment for acne vulgaris and method of use
GB0327723D0 (en) 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
WO2006006963A2 (en) 2004-04-02 2006-01-19 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Aerosol delivery systems and methods
US7563443B2 (en) 2004-09-17 2009-07-21 Domantis Limited Monovalent anti-CD40L antibody polypeptides and compositions thereof
GB0521621D0 (en) 2005-10-24 2005-11-30 Domantis Ltd Tumor necrosis factor receptor 1 antagonists for treating respiratory diseases
CA2588892A1 (en) 2004-12-02 2006-06-08 Dormantis Limited Anti-il-1r1 single domain antibodies and therapeutic uses
JP2009523460A (ja) 2006-01-24 2009-06-25 ドマンティス リミテッド Il−4および/またはil−13に結合するリガンド
US8225785B2 (en) 2006-10-03 2012-07-24 Smiths Medical Asd, Inc. Vibratory PEP therapy system with medicated aerosol nebulizer
JP2010518839A (ja) 2007-02-21 2010-06-03 アブリンクス エン.ヴェー. 血管内皮増殖因子に指向性を有するアミノ酸配列、及び過度の及び/もしくは病的な血管形成又は血管新生を特徴とする症状及び疾患を治療するためにこれを含むポリペプチド
WO2008116165A2 (en) 2007-03-21 2008-09-25 Next Safety, Inc. Methods and systems of delivering medication via inhalation
CN101796072B (zh) 2007-05-24 2014-09-24 埃博灵克斯股份有限公司 用于治疗骨疾病和病症的针对rank-l的氨基酸序列以及包括其的多肽
WO2010008424A2 (en) 2008-04-04 2010-01-21 Novartis Ag Aerosolization device
AU2009254501B2 (en) * 2008-06-05 2014-07-31 Ablynx N.V. Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases
WO2010065616A1 (en) 2008-12-02 2010-06-10 Thermocure, Inc. Systems and methods for delivery of a breathing gas with fine ice particles
EP2403531A4 (en) * 2009-03-05 2013-02-27 Abbott Lab IL-17 BINDING PROTEINS
ES2643034T3 (es) 2009-06-05 2017-11-21 Ablynx N.V. Construcciones de Nanobody contra el virus respiratorio sincicial humano (VRSH) trivalentes para la prevención y/o el tratamiento de infecciones de las vías respiratorias
PL2464664T3 (pl) * 2009-08-13 2016-02-29 Crucell Holland Bv Przeciwciała przeciwko ludzkiemu syncytialnemu wirusowi oddechowemu (RSV) i sposoby zastosowania
US9352107B2 (en) 2010-01-07 2016-05-31 Koninklijke Philips N.V. Respiratory drug delivery apparatus including a feedback and compliance device
PT3501499T (pt) * 2010-02-11 2022-11-22 Ablynx Nv Métodos e composições para a preparação de aerossóis
CN102985125A (zh) 2010-06-21 2013-03-20 曼金德公司 干粉药物输送系统和方法
CA3051326C (en) 2011-06-17 2022-01-11 Nostrum Technologies, Llc Mask for administration of inhaled medication
WO2013067164A1 (en) 2011-11-04 2013-05-10 Discovery Laboratories, Inc. Ventilation circuit adaptor and proximal aerosol delivery system
PT2797652T (pt) 2011-12-27 2019-02-19 Vectura Gmbh Dispositivo para inalação com sistema de feedback
CN104271187B (zh) 2012-03-09 2018-01-12 维克多瑞有限责任公司 吸入装置的混合通道与吸入装置
CN106986869A (zh) * 2012-04-17 2017-07-28 吉利德科学公司 用于抗病毒治疗的化合物和方法
PL2724741T3 (pl) 2012-10-26 2017-11-30 Vectura Gmbh Urządzenie inhalacyjne do stosowania w terapii aerozolowej
TWI659968B (zh) 2013-03-14 2019-05-21 再生元醫藥公司 針對呼吸道融合病毒f蛋白質的人類抗體及其使用方法

Similar Documents

Publication Publication Date Title
JP2017538779A5 (https=)
RU2017115670A (ru) Лечение инфекции рсв
EP3204095B1 (en) Inhalation device for use in aerosol therapy of respiratory diseases
AU2006235632B2 (en) Nitric oxide decontamination of the upper respiratory tract
EA200800905A1 (ru) Агенты, связывающиеся с мишенью в легочной ткани, для лечения респираторных заболеваний
JP2006513139A5 (https=)
TW200618810A (en) Treatment of respiratory syncytial virus (RSV) infection
WO2008012531A3 (en) Delivery of gases to the nasal airway
WO2006059108A3 (en) ANTI-IL-IRl SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC USES
US20150047635A1 (en) Duckbill valve and inhalation device including such a valve
JP2019513436A5 (https=)
Nitesh et al. What we learned in the past year in managing our COVID-19 patients in intensive care units?
WO2018099968A1 (en) Treatment of infection by respiratory syncytial virus (rsv)
AU2006225333A1 (en) Combination therapy of respiratory diseases using antibodies
WO2005110052A3 (en) The use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
KR20210097756A (ko) 폴리클로날 면역글로불린을 사용한 급성 악화를 예방하거나 치료하기 위한 방법 및 조성물
CN104436386B (zh) 辅助呼吸气雾气体的装置及调节呼吸气雾气体的方法
CN204233551U (zh) 辅助呼吸气雾气体的装置
HK1235327B (en) Inhalation device for use in aerosol therapy of respiratory diseases
HK1235327A1 (en) Inhalation device for use in aerosol therapy of respiratory diseases
Currie 5.1 Inhalers
NZ730120B2 (en) Inhalation device for use in aerosol therapy of respiratory diseases
Wongtrakool et al. A78 AIRWAY SMOOTH MUSCLE: WHAT'S UNDER THE HOOD?: Nicotine-Induced Airway Hyperresponsiveness May Be Due To Inappropriate Lynx1 Levels In Airway Smooth Muscle Cells
Pearce Teaching technique: Part 1
Oden et al. STOP-ROP Effective FiO2 Conversion Tables for Infants on Nasal Cannula